Schedule 13G ownership disclosure

SERES THERAPEUTICS INC

Security class unavailable · CUSIP: 81750R102

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,874,358
Percent of class
4.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000834237-22-010496
Form type
SC 13G
Filer
BlackRock Finance, Inc.
CIK
CIK 1364742
Filed
Aug 09, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub